Carnosine
| Names | |
|---|---|
| IUPAC name
β-Alanylhistidine | |
| Systematic IUPAC name
(2S)-2-(3-Aminopropanamido)-3-(3H-imidazol-4-yl)propanoic acid | |
| Other names
β-Alanyl-L-histidine | |
| Identifiers | |
3D model (JSmol) |
|
| ChEBI | |
| ChEMBL | |
| ChemSpider | |
| ECHA InfoCard | 100.005.610 |
| KEGG | |
PubChem CID |
|
| UNII | |
CompTox Dashboard (EPA) |
|
| |
| |
| Properties | |
| C9H14N4O3 | |
| Molar mass | 226.236 g·mol−1 |
| Appearance | Crystalline solid |
| Melting point | 253 °C (487 °F; 526 K) (decomposition) |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references | |
Carnosine (beta-alanyl-L-histidine) is a dipeptide molecule, made up of the amino acids beta-alanine and histidine. It is highly concentrated in muscle and brain tissues. Carnosine was discovered by Russian chemist Vladimir Gulevich.
Carnosine is naturally produced by the body in the liver from beta-alanine and histidine. Like carnitine, carnosine is composed of the root word carn, meaning "flesh", alluding to its prevalence in meat. There are no plant-based sources of carnosine. Carnosine is readily available as a synthetic nutritional supplement.
Carnosine can chelate divalent metal ions. Carnosine is also considered a geroprotectant.
Products containing carnosine are also used in topical preparations to reduce wrinkles on the skin.
Carnosine may increase the Hayflick limit in human fibroblasts, it also appears to reduce the rate of telomere shortening. This could potentially promote the growth of certain cancers that thrive due to telomere preservation.